ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2024-5907

A privilege escalation (PE) vulnerability in the Palo Alto Networks Cortex XDR agent on Windows devices enables a local user to execute programs with elevated privileges.

Published Jun 12, 2024 · catalog updated Nov 3, 2026 · cortex xdr agent

Last checked Nov 6, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2024-5907. EPSS is 0.13%. Act only if a listed version of cortex xdr agent is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.

Same product and reporting

Severity
Medium5.2
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.13%
Remediation
Version ranges on file
Affected products
cpe paloaltonetworks/cortex xdr agent

A privilege escalation (PE) vulnerability in the Palo Alto Networks Cortex XDR agent on Windows devices enables a local user to execute programs with elevated privileges. However, execution does require the local user to successfully exploit a race condition, which makes this vulnerability difficult to exploit.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe paloaltonetworks/cortex xdr agent< 7.9.102
  • cpe paloaltonetworks/cortex xdr agent< 8.2.3
  • cpe paloaltonetworks/cortex xdr agent< 8.3.1

How to fix CVE-2024-5907

  • Upgrade

    CVE-2024-5907 lists a fix boundary at 7.9.102. Compare the installed build with that boundary before you change production.

  • Version check

    Affected < 7.9.102

  • Advisory

    Open the cve_org record and follow its fix.

  • Official advisories

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2024-5907. EPSS is 0.13%. Act only if a listed version of cortex xdr agent is installed.

Which versions are affected?

Compare what you have installed with paloaltonetworks/cortex xdr agent < 7.9.102; paloaltonetworks/cortex xdr agent < 8.2.3; paloaltonetworks/cortex xdr agent < 8.3.1. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-269: Improper Privilege Management. EPSS 0.13%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Palo Alto PAN-OS securityWindows security

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jun 12, 2024 · NIST NVD

    Detected

    A privilege escalation (PE) vulnerability in the Palo Alto Networks Cortex XDR agent on Windows devices enables a local user to execute programs with elevated privileges. However, execution does require the local user to successfully exploit a race condition, which makes this vulnerability difficult to exploit.

  2. Nov 3, 2026 · NIST NVD

    Updated

    A privilege escalation (PE) vulnerability in the Palo Alto Networks Cortex XDR agent on Windows devices enables a local user to execute programs with elevated privileges. However, execution does require the local user to successfully exploit a race condition, which makes this vulnerability difficult to exploit.

Sources

  • CVE.orgVulnerability recordCVE-2024-5907

    Official CVE identifier

    cve.org
  • NIST NVDVulnerability recordCVE-2024-5907

    A privilege escalation (PE) vulnerability in the Palo Alto Networks Cortex XDR agent on Windows devices enables a local user to execute programs with elevated privileges. However, execution does require the local user to successfully exploit a race condition, which makes this vul

    nvd.nist.gov

References

Freshness

Last verified in this catalog Nov 6, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • CVE.orgNov 4, 2026
  • NIST NVDNov 4, 2026